How norepinephrine affects brain signaling and attention
Postsynaptic Signaling by Norepinephrine and cAMP
This study is looking at how a brain chemical called norepinephrine affects our attention and alertness, which could help us understand and improve conditions like ADHD and Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11000825 on NIH RePORTER |
What this research studies
This research investigates how norepinephrine, a neurotransmitter, influences attention and alertness in the brain. It focuses on the β2 adrenergic receptor, which plays a crucial role in signaling at synapses, particularly in how it interacts with other proteins to enhance neuronal communication. The study aims to understand the mechanisms by which norepinephrine enters neurons and promotes the delivery of receptors to the cell surface, potentially improving memory and learning processes. By examining these signaling pathways, the research seeks to uncover new insights into conditions like ADHD and Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with ADHD or Alzheimer's disease who may benefit from improved cognitive function.
Not a fit: Patients with conditions unrelated to norepinephrine signaling or those not experiencing cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance attention and memory in patients with ADHD and Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding norepinephrine's role in cognitive function, indicating that this approach has potential for significant advancements.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Hell, Johannes W — University of California at Davis
- Study coordinator: Hell, Johannes W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.